+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Spatial Genomics and Transcriptomics Market by Technique, Product Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 311 Pages
  • February 2022
  • Region: Global
  • Allied Market Research
  • ID: 5578217
The global spatial genomics and transcriptomics market was valued at $626.9 million in 2020 and is projected to reach $2,159.61 million by 2030, registering a CAGR of 13.6% from 2021 to 2030.



The studies of all genes and their associated mRNAs are correspondingly called genomics and transcriptomics. It is a method usually designed to assign cell types (mainly identified by mRNA readouts) to their locations in histological sections. This method can also be used to determine subcellular localization of mRNA molecules and their cellular heterogeneity in tissues, and tumors. In addition, spatial genomics and transcriptomics also provides information regarding immune cells as well as determine subcellular distribution of transcripts in various conditions.

Spatial genomics has tremendous potential in disease control as it helps to provide quantitative gene expression results, coupled with DNA & RNA visualization mapping within tissue parts. In spatial transcriptomics, sequencing techniques have a major share due to wide availability of sequencing platforms that help study RNA architecture in tissues or cells and use of advanced techniques within a laboratory setup to study biological organisms, which needs trained experts such as researchers and technicians. Genomics provides an overview of the complete set of genetic instructions provided by the DNA, while transcriptomics looks into gene expression patterns. The main driving factor that drives growth of the spatial genomics and transcriptomics market include, increase in adoption of spatial genomics and transcriptomics owing to its various application.

In addition, rise in prevalence of genetic disorders and applications of spatial genomics and transcriptomics in determination of disease and treatment markers, further supplement the global spatial genomics and transcriptomics market growth. Furthermore, growing preference toward personalized medicines also fuels growth of the market.

Conversely, unavailability of skilled professionals and ethical & legal limitations associated with the use of spatial genomics and transcriptomics technologies are expected to obstruct the growth of the market during forecast years. On the other hand, growth in innovations in spatial genomics and transcriptomics technologies are expected to offer profitable opportunities for the growth of the market during the forecast period.

The global spatial genomics and transcriptomics market is segmented on the basis of technique, product type, application, end user and region to provide a detailed assessment of the market. By technique, it is bifurcated into spatial transcriptomics, and spatial genomics analysis. The spatial transcriptomics is segmented into microdissection, fluorescent in-situ hybridization, in-situ sequencing, in-situ capturing, and in-silico construction.

In addition, the spatial genomics analysis is segmented into, fluorescence in-situ sequencing, and fluorescence microscopy. By product type, it is segmented into instruments, consumables, and software. By application, it is divided into, translational research, and drug discovery & development. Based on end user, it is segmented into pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key market players profiled in the report include 10X Genomics, Inc., Akoya Biosciences, Inc., BioSpyder Technologies Inc., Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.), Dovetail Genomics, LLC, Fluidigm Corporation, Genomic Vision SA, Illumina, Inc., Lunaphore Technologies SA, Nanostring Technologies, Inc., Natera Inc., PerkinElmer Inc. (Horizon Discovery Group Plc), Rarecyte, Inc., Rebus Biosystems, LLC, Resolve Biosciences, S2 Genomic, Seven Bridges Genomics, Singular Genomics System, Inc., Tecan Group Ltd. (Nugen Technologies, Inc.), Ultivue, Inc., Veranome Biosystems LLC, and Vizgen Corporation.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global spatial genomics and transcriptomics market along with the current trends and future estimations to elucidate the imminent investment pockets
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities
  • Extensive analysis of the key segments of the industry helps to understand the application and products of spatial genomics and transcriptomics used across the globe
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market

KEY MARKET SEGMENTS


By Technique

  • Spatial Transcriptomics
  • Microdissection
  • Fluorescent In-situ hybridization
  • In-situ sequencing
  • In-situ capturing
  • In-silico construction
  • Spatial Genomics Analysis
  • Fluorescence In-situ sequencing
  • Fluorescence Microscopy

By Product Type

  • Instruments
  • Consumables
  • Software

By Application

  • Translational Research
  • Drug Discovery & Development

By End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic & Research Institutes

By Region

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East and Africa

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • 10X Genomics, Inc
  • Akoya Biosciences, Inc
  • BioSpyder Technologies Inc
  • Bio-Techne Corporation (Advanced Cell Diagnostics, Inc)
  • Dovetail Genomics, LLC
  • Fluidigm Corporation
  • Genomic Vision SA
  • Illumina, Inc
  • Lunaphore Technologies SA
  • Nanostring Technologies, Inc
  • Natera Inc
  • PerkinElmer Inc (Horizon Discovery Group Plc)
  • Rarecyte, Inc
  • Rebus Biosystems, LLC
  • Resolve Biosciences
  • S2 Genomic
  • Seven Bridges Genomics
  • Singular Genomics System, Inc
  • Tecan Group Ltd (Nugen Technologies, Inc)
  • Ultivue, Inc
  • Veranome Biosystems LLC
  • Vizgen Corporation

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled in the Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models
Chapter 2: Executive Summary
2.1. Key Findings of the Study
2.2. Cxo Perspective
Chapter 3: Market Landscape
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter’S Five Force Analysis
3.4. Top Player Positioning, 2020
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Increase in Adoption of Spatial Genomics and Transcriptomics Technologies
3.5.1.2. Rise in Prevalence of Genetic Disorders
3.5.1.3. Growth in Preference Toward Personalized Medicines
3.5.2. Restraints
3.5.2.1. Dearth of Skilled Professionals
3.5.2.2. Ethical & Legal Limitations
3.5.3. Opportunity
3.5.3.1. Growth in Innovations in Spatial Genomics and Transcriptomics Technologies
3.5.4. Impact Analysis
3.6. Covid-19 Impact Analysis on the Spatial Genomics and Transcriptomics Market
Chapter 4: Spatial Genomics and Transcriptomics Market, by Technique
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Spatial Transcriptomics
4.2.1. Key Market Trends, Growth Factors, and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Analysis, by Country
4.2.4. Market Size and Forecast, by Type
4.2.5. Microdissection
4.2.5.1. Market Size and Forecast
4.2.6. Fluorescent In-Situ Hybridization
4.2.6.1. Market Size and Forecast
4.2.7. In-Situ Sequencing
4.2.7.1. Market Size and Forecast
4.2.8. In-Situ Capturing
4.2.8.1. Market Size and Forecast
4.2.9. In-Silico Construction
4.2.9.1. Market Size and Forecast
4.3. Spatial Genomics Analysis
4.3.1. Key Market Trends, Growth Factors, and Opportunities
4.3.2. Market Size and Forecast
4.3.3. Market Analysis, by Country
4.3.4. Market Size and Forecast, by Type
4.3.5. Fluorescence In-Situ Sequencing
4.3.5.1. Market Size and Forecast
4.3.6. Fluorescence Microscopy
4.3.6.1. Market Size and Forecast
Chapter 5: Spatial Genomics and Transcriptomics Market, by Product Type
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Instruments
5.2.1. Market Size and Forecast, by Region
5.2.2. Market Analysis, by Country
5.3. Consumables
5.3.1. Market Size and Forecast, by Region
5.3.2. Market Analysis, by Country
5.4. Software
5.4.1. Market Size and Forecast, by Region
5.4.2. Market Analysis, by Country
Chapter 6: Spatial Genomics and Transcriptomics Market, Application
6.1. Overview
6.1.1. Market Size and Forecast
6.2. Translational Research
6.2.1. Market Size and Forecast, by Region
6.2.2. Market Analysis, by Country
6.3. Drug Discovery & Development
6.3.1. Market Size and Forecast, by Region
6.3.2. Market Analysis, by Country
Chapter 7: Spatial Genomics and Transcriptomics Market, by End-user
7.1. Overview
7.1.1. Market Size and Forecast
7.2. Pharmaceutical & Biotechnology Companies
7.2.1. Market Size and Forecast, by Region
7.2.2. Market Analysis, by Country
7.3. Contract Research Organizations
7.3.1. Market Size and Forecast
7.3.2. Market Analysis, by Country
7.4. Academic & Research Institutes
7.4.1. Market Size and Forecast
7.4.2. Market Analysis, by Country
Chapter 8: Spatial Genomics and Transcriptomics Market, by Region
8.1. Overview
8.1.1. Market Size and Forecast
8.2. North America
8.2.1. Key Market Trends, Growth Factors, and Opportunities
8.2.2. Market Size and Forecast, by Country
8.2.2.1. U. S.
8.2.2.1.1. U. S. Spatial Genomics and Transcriptomics Market, by Technique
8.2.2.1.2. U. S. Spatial Genomics and Transcriptomics Market, by Product Type
8.2.2.1.3. U. S. Spatial Genomics and Transcriptomics Market, by Application
8.2.2.1.4. U. S. Spatial Genomics and Transcriptomics Market, by End-user
8.2.2.2. Canada
8.2.2.2.1. Canada Spatial Genomics and Transcriptomics Market, by Technique
8.2.2.2.2. Canada Spatial Genomics and Transcriptomics Market, by Product Type
8.2.2.2.3. Canada Spatial Genomics and Transcriptomics Market, by Application
8.2.2.2.4. Canada Spatial Genomics and Transcriptomics Market, by End-user
8.2.2.3. Mexico
8.2.2.3.1. Mexico Spatial Genomics and Transcriptomics Market, by Technique
8.2.2.3.2. Mexico Spatial Genomics and Transcriptomics Market, by Product Type
8.2.2.3.3. Mexico Spatial Genomics and Transcriptomics Market, by Application
8.2.2.3.4. Mexico Spatial Genomics and Transcriptomics Market, by End-user
8.2.3. North America Market Size and Forecast, by Technique
8.2.3.1. North America Market Size and Forecast, by Spatial Transcriptomics
8.2.3.2. North America Market Size and Forecast, by Spatial Genomics Analysis
8.2.4. North America Market Size and Forecast, by Product Type
8.2.5. North America Market Size and Forecast, by Application
8.2.6. North America Market Size and Forecast, by End-user
8.3. Europe
8.3.1. Key Market Trends, Growth Factors, and Opportunities
8.3.2. Market Size and Forecast, by Country
8.3.2.1. Germany
8.3.2.1.1. Germany Spatial Genomics and Transcriptomics Market, by Technique
8.3.2.1.2. Germany Spatial Genomics and Transcriptomics Market, by Product Type
8.3.2.1.3. Germany Spatial Genomics and Transcriptomics Market, by Application
8.3.2.1.4. Germany Spatial Genomics and Transcriptomics Market, by End-user
8.3.2.2. France
8.3.2.2.1. France Spatial Genomics and Transcriptomics Market, by Technique
8.3.2.2.2. France Spatial Genomics and Transcriptomics Market, by Product Type
8.3.2.2.3. France Spatial Genomics and Transcriptomics Market, by Application
8.3.2.2.4. France Spatial Genomics and Transcriptomics Market, by End-user
8.3.2.3. Uk
8.3.2.3.1. Uk Spatial Genomics and Transcriptomics Market, by Technique
8.3.2.3.2. Uk Spatial Genomics and Transcriptomics Market, by Product Type
8.3.2.3.3. Uk Spatial Genomics and Transcriptomics Market, by Application
8.3.2.3.4. Uk Spatial Genomics and Transcriptomics Market, by End-user
8.3.2.4. Italy
8.3.2.4.1. Italy Spatial Genomics and Transcriptomics Market, by Technique
8.3.2.4.2. Italy Spatial Genomics and Transcriptomics Market, by Product Type
8.3.2.4.3. Italy Spatial Genomics and Transcriptomics Market, by Application
8.3.2.4.4. Italy Spatial Genomics and Transcriptomics Market, by End-user
8.3.2.5. Spain
8.3.2.5.1. Spain Spatial Genomics and Transcriptomics Market, by Technique
8.3.2.5.2. Spain Spatial Genomics and Transcriptomics Market, by Product Type
8.3.2.5.3. Spain Spatial Genomics and Transcriptomics Market, by Application
8.3.2.5.4. Spain Spatial Genomics and Transcriptomics Market, by End-user
8.3.2.6. Rest of Europe
8.3.2.6.1. Rest of Europe Spatial Genomics and Transcriptomics Market, by Technique
8.3.2.6.2. Rest of Europe Spatial Genomics and Transcriptomics Market, by Product Type
8.3.2.6.3. Rest of Europe Spatial Genomics and Transcriptomics Market, by Application
8.3.2.6.4. Rest of Europe Spatial Genomics and Transcriptomics Market, by End-user
8.3.3. Europe Market Size and Forecast, by Technique
8.3.3.1. Europe Market Size and Forecast, by Spatial Transcriptomics
8.3.3.2. Europe Market Size and Forecast, by Spatial Genomics Analysis
8.3.4. Europe Market Size and Forecast, by Product Type
8.3.5. Europe Market Size and Forecast, by Application
8.3.6. Europe Market Size and Forecast, by End-user
8.4. Asia-Pacific
8.4.1. Key Market Trends, Growth Factors, and Opportunities
8.4.2. Market Size and Forecast, by Country
8.4.2.1. Japan
8.4.2.1.1. Japan Spatial Genomics and Transcriptomics Market, by Technique
8.4.2.1.2. Japan Spatial Genomics and Transcriptomics Market, by Product Type
8.4.2.1.3. Japan Spatial Genomics and Transcriptomics Market, by Application
8.4.2.1.4. Japan Spatial Genomics and Transcriptomics Market, by End-user
8.4.2.2. China
8.4.2.2.1. China Spatial Genomics and Transcriptomics Market, by Technique
8.4.2.2.2. China Spatial Genomics and Transcriptomics Market, by Product Type
8.4.2.2.3. China Spatial Genomics and Transcriptomics Market, by Application
8.4.2.2.4. China Spatial Genomics and Transcriptomics Market, by End-user
8.4.2.3. Australia
8.4.2.3.1. Australia Spatial Genomics and Transcriptomics Market, by Technique
8.4.2.3.2. Australia Spatial Genomics and Transcriptomics Market, by Product Type
8.4.2.3.3. Australia Spatial Genomics and Transcriptomics Market, by Application
8.4.2.3.4. Australia Spatial Genomics and Transcriptomics Market, by End-user
8.4.2.4. India
8.4.2.4.1. India Spatial Genomics and Transcriptomics Market, by Technique
8.4.2.4.2. India Spatial Genomics and Transcriptomics Market, by Product Type
8.4.2.4.3. India Spatial Genomics and Transcriptomics Market, by Application
8.4.2.4.4. India Spatial Genomics and Transcriptomics Market, by End-user
8.4.2.5. South Korea
8.4.2.5.1. South Korea Spatial Genomics and Transcriptomics Market, by Technique
8.4.2.5.2. South Korea Spatial Genomics and Transcriptomics Market, by Product Type
8.4.2.5.3. South Korea Spatial Genomics and Transcriptomics Market, by Application
8.4.2.5.4. South Korea Spatial Genomics and Transcriptomics Market, by End-user
8.4.2.6. Rest of Asia-Pacific
8.4.2.6.1. Rest of Asia-Pacific Spatial Genomics and Transcriptomics Market, by Technique
8.4.2.6.2. Rest of Asia-Pacific Spatial Genomics and Transcriptomics Market, by Product Type
8.4.2.6.3. Rest of Asia-Pacific Spatial Genomics and Transcriptomics Market, by Application
8.4.2.6.4. Rest of Asia-Pacific Spatial Genomics and Transcriptomics Market, by End-user
8.4.3. Asia-Pacific Market Size and Forecast, by Technique
8.4.3.1. Asia-Pacific Market Size and Forecast, by Spatial Transcriptomics
8.4.3.2. Asia-Pacific Market Size and Forecast, by Spatial Genomics Analysis
8.4.4. Asia-Pacific Market Size and Forecast, by Product Type
8.4.5. Asia-Pacific Market Size and Forecast, by Application
8.4.6. Asia-Pacific Market Size and Forecast, by End-user
8.5. Lamea
8.5.1. Key Market Trends, Growth Factors, and Opportunities
8.5.2. Market Size and Forecast, by Country
8.5.2.1. Latin America
8.5.2.1.1. Latin America Spatial Genomics and Transcriptomics Market, by Technique
8.5.2.1.2. Latin America Spatial Genomics and Transcriptomics Market, by Product Type
8.5.2.1.3. Latin America Spatial Genomics and Transcriptomics Market, by Application
8.5.2.1.4. Latin America Spatial Genomics and Transcriptomics Market, by End-user
8.5.2.2. Middle East and Africa
8.5.2.2.1. Middle East and Africa Spatial Genomics and Transcriptomics Market, by Technique
8.5.2.2.2. Middle East and Africa Spatial Genomics and Transcriptomics Market, by Product Type
8.5.2.2.3. Middle East and Africa Spatial Genomics and Transcriptomics Market, by Application
8.5.2.2.4. Middle East and Africa Spatial Genomics and Transcriptomics Market, by End-user
8.5.3. Lamea Market Size and Forecast, by Technique
8.5.3.1. Lamea Market Size and Forecast, by Spatial Transcriptomics
8.5.3.2. Lamea Market Size and Forecast, by Spatial Genomics Analysis
8.5.4. Lamea Market Size and Forecast, by Product Type
8.5.5. Lamea Market Size and Forecast, by Application
8.5.6. Lamea Market Size and Forecast, by End-user
Chapter 9: Company Profiles
9.1.10X Genomics, Inc.
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Operating Business Segments
9.1.4. Product Portfolio
9.1.5. Business Performance
9.2. Akoya Biosciences, Inc.
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Operating Business Segments
9.2.4. Product Portfolio
9.2.5. Business Performance
9.2.6. Key Strategic Moves and Developments
9.3. Biospyder Technologies Inc.
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Operating Business Segments
9.3.4. Product Portfolio
9.4. Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.)
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Operating Business Segments
9.4.4. Product Portfolio
9.4.5. Business Performance
9.5. Dovetail Genomics LLC.
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Operating Business Segments
9.5.4. Product Portfolio
9.5.5. Key Strategic Moves and Developments
9.6. Fluidigm Corporation
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Operating Business Segments
9.6.4. Product Portfolio
9.6.5. Business Performance
9.6.6. Key Strategic Moves and Developments
9.7. Genomic Vision Sa
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Operating Business Segments
9.7.4. Product Portfolio
9.7.5. Business Performance
9.8. Illumina Inc.
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Operating Business Segments
9.8.4. Product Portfolio
9.8.5. Business Performance
9.8.6. Key Strategic Moves and Developments
9.9. Lunaphore Technologies Sa
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Operating Business Segments
9.9.4. Product Portfolio
9.10. Nanostring Technologies, Inc
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Operating Business Segments
9.10.4. Product Portfolio
9.10.5. Business Performance
9.10.6. Key Strategic Moves and Developments
9.11. Natera Inc.
9.11.1. Company Overview
9.11.2. Company Snapshot
9.11.3. Operating Business Segments
9.11.4. Product Portfolio
9.11.5. Business Performance
9.12. Perkinelmer Inc. (Advanced Cell Diagnostics, Inc.)
9.12.1. Company Overview
9.12.2. Company Snapshot
9.12.3. Operating Business Segments
9.12.4. Product Portfolio
9.12.5. Business Performance
9.13. Rarecyte, Inc.
9.13.1. Company Overview
9.13.2. Company Snapshot
9.13.3. Operating Business Segments
9.13.4. Product Portfolio
9.13.5. Key Strategic Moves and Developments
9.14. Rebus Biosystems, Inc.
9.14.1. Company Overview
9.14.2. Company Snapshot
9.14.3. Operating Business Segments
9.14.4. Product Portfolio
9.14.5. Key Strategic Moves and Developments
9.15. Resolve Biosciences
9.15.1. Company Overview
9.15.2. Company Snapshot
9.15.3. Operating Business Segments
9.15.4. Product Portfolio
9.15.5. Key Strategic Moves and Developments
9.16. S2 Genomics Inc.
9.16.1. Company Overview
9.16.2. Company Snapshot
9.16.3. Operating Business Segments
9.16.4. Product Portfolio
9.16.5. Key Strategic Moves and Developments
9.17. Seven Bridges Genomics, Inc.
9.17.1. Company Overview
9.17.2. Company Snapshot
9.17.3. Operating Business Segments
9.17.4. Product Portfolio
9.18. Singular Genomics Systems, Inc.
9.18.1. Company Overview
9.18.2. Company Snapshot
9.18.3. Operating Business Segments
9.18.4. Product Portfolio
9.18.5. Key Strategic Moves and Developments
9.19. Tecan Group Ltd. (Nugen Technologies, Inc.)
9.19.1. Company Overview
9.19.2. Company Snapshot
9.19.3. Operating Business Segments
9.19.4. Product Portfolio
9.19.5. Business Performance
9.20. Ultivue, Inc.
9.20.1. Company Overview
9.20.2. Company Snapshot
9.20.3. Operating Business Segments
9.20.4. Product Portfolio
9.20.5. Key Strategic Moves and Developments
9.21. Veranome Biosystems LLC
9.21.1. Company Overview
9.21.2. Company Snapshot
9.21.3. Operating Business Segments
9.21.4. Product Portfolio
9.22. Vizgen Corporation
9.22.1. Company Overview
9.22.2. Company Snapshot
9.22.3. Operating Business Segments
9.22.4. Product Portfolio
List of Tables
Table 01. Global Spatial Genomics and Transcriptomic Market, by Technique, 2020-2030 ($Million)
Table 02. Spatial Genomics and Transcriptomic Market for Spatial Transcriptomics, by Region, 2020-2030 ($Million)
Table 03. Spatial Genomics and Transcriptomic Market, for Spatial Transcriptomics, by Type, 2020–2030, ($Million)
Table 04. Spatial Genomics and Transcriptomic Market for Spatial Genomics Analysis, by Region, 2020-2030 ($Million)
Table 05. Spatial Genomics and Transcriptomic Market, for Spatial Genomics Analysis, by Type, 2020–2030, ($Million)
Table 06. Global Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 07. Spatial Genomics and Transcriptomics Market for Instruments, by Region, 2020-2030 ($Million)
Table 08. Spatial Genomics and Transcriptomics Market for Consumables, by Region, 2020-2030 ($Million)
Table 09. Spatial Genomics and Transcriptomics Market for Software, by Region, 2020-2030 ($Million)
Table 10. Global Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 11. Spatial Genomics and Transcriptomics Market for Translational Research, by Region, 2020-2030 ($Million)
Table 12. Spatial Genomics and Transcriptomics Market for Drug Discovery & Development, by Region, 2020-2030 ($Million)
Table 13. Global Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 14. Spatial Genomics and Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Region, 2020-2030 ($Million)
Table 15. Spatial Genomics and Transcriptomics Market for Contract Research Organizations, by Region, 2020-2030 ($Million)
Table 16. Spatial Genomics and Transcriptomics Market for Academic & Research Institutes, by Region, 2020-2030 ($Million)
Table 17. Spatial Genomics and Transcriptomics Market, by Region, 2020-2030 ($Million)
Table 18. North America Spatial Genomics and Transcriptomics Market, by Country, 2020-2030 ($Million)
Table 19. U.S Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 20. U.S Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 21. U.S Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 22. U.S Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 23. Canada Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 24. Canada Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 25. Canada Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 26. Canada Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 27. Mexico Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 28. Mexico Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 29. Mexico Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 30. Mexico Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 31. North America Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 32. North America Spatial Genomics and Transcriptomics Market, by Spatial Transcriptomics, 2020-2030 ($Million)
Table 33. North America Spatial Genomics and Transcriptomics Market, by Spatial Genomics Analysis, 2020-2030 ($Million)
Table 34. North America Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 35. North America Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 36. North America Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 37. Europe Spatial Genomics and Transcriptomics Market, by Country, 2020-2030 ($Million)
Table 38. Germany Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 39. Germany Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 40. Germany Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 41. Germany Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 42. France Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 43. France Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 44. France Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 45. France Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 46. Uk Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 47. Uk Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 48. Uk Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 49. Uk Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 50. Italy Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 51. Italy Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 52. Italy Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 53. Italy Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 54. Spain Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 55. Spain Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 56. Spain Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 57. Spain Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 58. Rest of Europe Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 59. Rest of Europe Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 60. Rest of Europe Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 61. Rest of Europe Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 62. Europe Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 63. Europe Spatial Genomics and Transcriptomics Market, by Spatial Transcriptomics, 2020-2030 ($Million)
Table 64. Europe Spatial Genomics and Transcriptomics Market, by Spatial Genomics Analysis, 2020-2030 ($Million)
Table 65. Europe Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 66. Europe Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 67. Europe Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 68. Asia-Pacific Spatial Genomics and Transcriptomics Market, by Country, 2020-2030 ($Million)
Table 69. Japan Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 70. Japan Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 71. Japan Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 72. Japan Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 73. China Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 74. China Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 75. China Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 76. China Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 77. Australia Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 78. Australia Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 79. Australia Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 80. Australia Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 81. India Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 82. India Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 83. India Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 84. India Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 85. South Korea Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 86. South Korea Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 87. South Korea Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 88. South Korea Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 89. Rest of Asia-Pacific Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 90. Rest of Asia-Pacific Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 91. Rest of Asia-Pacific Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 92. Rest of Asia-Pacific Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 93. Asia-Pacific Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 94. Asia-Pacific Spatial Genomics and Transcriptomics Market, by Spatial Transcriptomics, 2020-2030 ($Million)
Table 95. Asia-Pacific Spatial Genomics and Transcriptomics Market, by Spatial Genomics Analysis, 2020-2030 ($Million)
Table 96. Asia-Pacific Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 97. Asia-Pacific Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 98. Asia-Pacific Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 99. Lamea Spatial Genomics and Transcriptomics Market, by Country, 2020-2030 ($Million)
Table 100. Latin America Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 101. Latin America Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 102. Latin America Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 103. Latin America Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 104. Middle East and Africa Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 105. Middle East and Africa Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 106. Middle East and Africa Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 107. Middle East and Africa Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 108. Lamea Spatial Genomics and Transcriptomics Market, by Technique, 2020-2030 ($Million)
Table 109. Lamea Spatial Genomics and Transcriptomics Market, by Spatial Transcriptomics, 2020-2030 ($Million)
Table 110. Lamea Spatial Genomics and Transcriptomics Market, by Spatial Genomics Analysis, 2020-2030 ($Million)
Table 111. Lamea Spatial Genomics and Transcriptomics Market, by Product Type, 2020-2030 ($Million)
Table 112. Lamea Spatial Genomics and Transcriptomics Market, by Application, 2020-2030 ($Million)
Table 113. Lamea Spatial Genomics and Transcriptomics Market, by End-user, 2020-2030 ($Million)
Table 114. 10X Genomics Inc. : Company Snapshot
Table 115. 10X Genomics: Operating Segment
Table 116. 10X Genomics Inc. : Product Portfolio
Table 117. Akoya Biosciences Inc. : Company Snapshot
Table 118. Akoya Biosciences: Product Segments
Table 119. Akoya Biosciences Inc. : Product Portfolio
Table 120. Akoya Biosciences Inc. : Key Strategic Moves and Developments
Table 121. Biospyder Technologies: Company Snapshot
Table 122. Biospyder Technologies: Operating Segments
Table 123. Biospyder Technologies: Product Portfolio
Table 124. Bio-Techne Corporation: Company Snapshot
Table 125. Bio-Techne Corporation: Operating Segment
Table 126. Bio-Techne Corporation: Product Portfolio
Table 127. Dovetail Genomics LLC: Company Snapshot
Table 128. Dovetail Genomics LLC: Operating Segments
Table 129. Dovetail Genomics LLC: Product Portfolio
Table 130. Dovetail Genomics LLC: Key Strategic Moves and Developments
Table 131. Fluidigm Corporation : Company Snapshot
Table 132. Fluidigm Corporation : Operating Segments
Table 133. Fluidigm Corporation : Product Portfolio
Table 134. Fluidigm: Key Strategic Moves and Developments
Table 135. Genomic Vision Sa: Company Snapshot
Table 136. Genomic Vision Sa: Operating Segments
Table 137. Genomic Vision Sa: Product Portfolio
Table 138. Illumina, Inc. : Company Snapshot
Table 139. Illumina, Inc. : Operating Segments
Table 140. Illumina, Inc. : Product Portfolio
Table 141. Ilumina Inc. : Key Strategic Moves and Developments
Table 142. Lunaphore Technologies Sa. : Company Snapshot
Table 143. Lunaphore Technologies Sa: Operating Segments
Table 144. Lunaphore Technologies Sa: Product Portfolio
Table 145. Nanostring Technologies Inc. : Company Snapshot
Table 146. Nanostring Technologies Inc. : Operating Segments
Table 147. Nanostring Technologies Inc. : Product Portfolio
Table 148. Nanostring Technologies: Key Strategic Moves and Developments
Table 149. Natera Inc. : Company Snapshot
Table 150. Natera Inc. : Operating Segments
Table 151. Natera Inc. : Product Portfolio
Table 152. Perkinelmer Inc. : Company Snapshot
Table 153. Perkinelmer Inc. : Operating Segments
Table 154. Perkin Elmer: Product Portfolio
Table 155. Rarecyte, Inc. : Company Snapshot
Table 156. Rarecyte, Inc. : Operating Segments
Table 157. Rarecyte, Inc. : Product Portfolio
Table 158. Rarecyte, Inc. : Key Strategic Moves and Developments
Table 159. Rebus Biosystems Inc. : Company Snapshot
Table 160. Rebus Biosystems: Operating Segments
Table 161. Rebus Biosystems: Product Portfolio
Table 162. Rebus Biosystems Inc. : Key Strategic Moves and Developments
Table 163. Resolve Biosciences. : Company Snapshot
Table 164. Resolve Biosciences: Operating Segments
Table 165. Resolve Biosciences: Product Portfolio
Table 166. Resolve Biosciences: Key Strategic Moves and Developments
Table 167. S2 Genomics Inc. : Company Snapshot
Table 168. S2 Genomics Inc. : Operating Segments
Table 169. S2 Genomics Inc. : Product Portfolio
Table 170. S2 Genomics Inc. : Key Strategic Moves and Developments
Table 171. Seven Bridges Genomics Inc. : Company Snapshot
Table 172. Seven Bridges Genomics Inc. : Operating Segments
Table 173. Seven Bridges Genomics Inc. : Product Portfolio
Table 174. Singular Genomics System Inc. : Company Snapshot
Table 175. Singular Genomics System Inc. : Operating Segments
Table 176. Singular Genomics System Inc. : Product Portfolio
Table 177. Singular Genomics Inc. : Key Strategic Moves and Developments
Table 178. Tecan Group Ltd. : Company Snapshot
Table 179. Tecan Group Ltd. : Operating Segments
Table 180. Tecan Group Ltd. : Product Portfolio
Table 181. Ultivue Inc. : Company Snapshot
Table 182. Ultivue Inc. : Operating Segments
Table 183. Ultivue Inc. : Product Portfolio
Table 184. Ultivue Inc. : Key Strategic Moves and Developments
Table 185. Veranome Biosystems LLC: Company Snapshot
Table 186. Veranome Biosystems LLC: Operating Segments
Table 187. Veranome Biosystems LLC: Product Portfolio
Table 188. Vizgen Corporation : Company Snapshot
Table 189. Vizgen Corporation: Operating Segments
Table 190. Vizgen Corporation : Product Portfolio
List of Figures
Figure 01. Spatial Genomics and Transcriptomics Market Segmentation
Figure 02. Top Investment Pockets
Figure 03. Top Winning Strategies, by Year, 2019-2022
Figure 04. Top Winning Strategies, by Development, 2019-2022
Figure 05. Top Winning Strategies, by Company, 2019-2022
Figure 06. Moderate Bargaining Power of Suppliers
Figure 07. Moderate Bargaining Power of Buyers
Figure 08. Low Threat of Substitutes
Figure 09. Moderate Threat of New Entrants
Figure 10. High Intensity of Rivalry
Figure 11. Top Player Positioning, 2020
Figure 12. Impact Analysis
Figure 13. Comparative Analysis of Spatial Genomics and Transcriptomic Market for Spatial Transcriptomics, by Country, 2020 & 2030 (%)
Figure 14. Spatial Genomics and Transcriptomic Market for Microdissection, 2020–2030, ($ Million)
Figure 15. Spatial Genomics and Transcriptomic Market for Fluorescent In-Situ Hybridization, 2020–2030, ($ Million)
Figure 16. Spatial Genomics and Transcriptomic Market for In-Situ Sequencing, 2020–2030, ($ Million)
Figure 17. Spatial Genomics and Transcriptomic Market for In-Situ Capturing, 2020–2030, ($ Million)
Figure 18. Spatial Genomics and Transcriptomic Market for In-Silico Construction, 2020–2030, ($ Million)
Figure 19. Comparative Analysis of Spatial Genomics and Transcriptomic Market for Spatial Genomics Analysis, by Country, 2020 & 2030 (%)
Figure 20. Spatial Genomics and Transcriptomic Market for Fluorescence In-Situ Sequencing, 2020–2030, ($ Million)
Figure 21. Spatial Genomics and Transcriptomic Market for Fluorescence Microscopy, 2020–2030, ($ Million)
Figure 22. Comparative Analysis Spatial Genomics and Transcriptomics Market for Instruments, by Country, 2020 & 2030 (%)
Figure 23. Comparative Analysis of Spatial Genomics and Transcriptomics Market for Consumables, by Country, 2020 & 2030 (%)
Figure 24. Comparative Analysis of Spatial Genomics and Transcriptomics Market for Software, by Country, 2020 & 2030 (%)
Figure 25. Comparative Analysis of Spatial Genomics and Transcriptomics Market for Translational Research, by Country, 2020 & 2030 ($ Million)
Figure 26. Comparative Analysis of Spatial Genomics and Transcriptomics Market for Drug Discovery & Development, by Country, 2020 & 2030 ($ Million)
Figure 27. Comparative Analysis of Spatial Genomics and Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Country, 2020 & 2030 (%)
Figure 28. Comparative Analysis of Spatial Genomics and Transcriptomics Market for Contract Research Organizations, by Country, 2020 & 2030 (%)
Figure 29. Comparative Analysis of Spatial Genomics and Transcriptomics Market for Academic & Research Institutes, by Country, 2020 & 2030 (%)
Figure 30. 10X Genomics Inc: Net Sales, 2018–2020 ($ Million)
Figure 31. 10X Genomics Inc: Revenue Share by Region, 2020 (%)
Figure 32. Akoya Biosciences Inc: Net Sales, 2018–2020 ($ Million)
Figure 33. Akoya Biosciences Inc: Revenue Share by Segment, 2020 (%)
Figure 34. Akoya Biosciences Inc: Revenue Share by Region, 2020 (%)
Figure 35. Bio-Techne Corporation: Net Sales, 2019–2021 ($ Million)
Figure 36. Bio-Techne Corporation: Revenue Share by Segment, 2020 (%)
Figure 37. Bio-Techne Corporation: Revenue Share by Region, 2020 (%)
Figure 38. Fluidigm Corporation: Net Sales, 2018–2020 ($ Million)
Figure 39. Fluidigm Corporation: Revenue Share by Region, 2020 (%)
Figure 40. Genomic Vision Sa: Net Sales, 2018–2020 ($ Million)
Figure 41. Genomic Vision Sa: Revenue Share by Region, 2020 (%)
Figure 42. Illumina, Inc: Net Sales, 2018–2020 ($ Million)
Figure 43. Illumina, Inc: Revenue Share by Segment, 2020 (%)
Figure 44. Illumina, Inc: Revenue Share, by Region, 2020 (%)
Figure 45. Nanostring Technologies Inc: Net Sales, 2018–2020 ($ Million)
Figure 46. Nanostring Technologies Inc: Revenue Share by Region, 2020 (%)
Figure 47. Natera Inc: Net Sales, 2018–2020 ($ Million)
Figure 48. Natera Inc: Revenue Share by Region, 2020 (%)
Figure 49. Perkin Elmer Inc: Net Sales, 2018–2020 ($ Million)
Figure 50. Perkin Elmer Inc: Revenue Share, by Segment, 2020 (%)
Figure 51. Perkin Elmer Inc: Revenue Share, by Region, 2020 (%)
Figure 52. Tecan Group Ltd: Net Sales, 2018–2020 ($ Million)
Figure 53. Tecan Group Ltd: Revenue Share by Segment, 2020 (%)
Figure 54. Tecan Group Ltd: Revenue Share, by Region, 2020 (%)

Executive Summary

According to a new report titled, “Spatial Genomics and Transcriptomic Market, by Technique, Product Type Application, End User: Global Opportunity Analysis and Industry Forecast, 2021–2030, the global spatial genomics and transcriptomic market size was valued at $0.62 billion in 2020 and is projected to reach $2.15 billion by 2030 registering a CAGR of 13.6% from 2021 to 2030.

Spatial genomics & transcriptomic is a new discipline involving the identification of high-performance information concerning the organizational composition of tissue and cell content. It is a method that uses mRNA readouts to assign cell types to their positions in histological sections. This method may also be used to determine the subcellular localization and cellular heterogeneity of mRNA molecules in cancers and organs.

In addition, spatial genomics and transcriptomics provide information on immune cells and characterize the subcellular distribution of transcripts in a variety of situations. Spatial genomics has a lot of potential in disease control because it provides quantitative gene expression data as well as DNA and RNA visualization mapping into tissue components. In addition, sequencing techniques have a significant role in spatial transcriptomics, due to the widespread availability of sequencing platforms that aid in the study of RNA architecture in cells or tissues as well as the employment of advanced techniques inside a laboratory setup to investigate biological organisms.

The major factors that impact the growth of the spatial genomics and transcriptomic market include increase in adoption of spatial genomics and transcriptomics technologies, owing to their various applications. In addition, growth in prevalence of genetic disorders and applications of spatial genomics and transcriptomics in determination of disease and treatment markers also boost the growth of the market. Furthermore, rise in preference toward personalized medicines also fuels the growth of the market.

However, unavailability of skilled professionals and ethical & legal limitations associated with the use of spatial genomics and transcriptomic technologies hamper the growth of the market. On the other hand, growth in innovations in spatial genomics and transcriptomic technologies are expected to offer profitable opportunities for the growth of the market during the forecast period.

COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. The global spatial genomics and transcriptomics market also declined in 2020 due to global economic recession led by COVID-19. However, market witness recovery in the year 2021, owing to increase in adoption of spatial genomics & transcriptomics to profile COVID-19 tissue autopsies as well as rise in biomarker identification and its use in drug discovery and development programs.

The global spatial genomics and transcriptomic market is segmented on the basis of technique, product type, application, end user, and region. By technique, it is bifurcated into spatial transcriptomics, and spatial genomics analysis. The spatial transcriptomics is further segmented into microdissection, fluorescent in-situ hybridization, in-situ sequencing, in-situ capturing, and in-silico construction. In addition, the spatial genomics analysis segment is segmented into, fluorescence in-situ sequencing, and fluorescence microscopy. The spatial genomics analysis segment was the major shareholder in 2020, owing to emerging potential of spatial genomic analysis as a cancer diagnostic tool, and advent of the fourth generation of sequencing.

By product type, it is segmented into instruments, consumables, and software. The consumables segment dominated the global spatial genomics and transcriptomic market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to increase in adoption of consumables that are required to run the instruments across various stages of genome mapping from sample preparation to result derivation. Based on application, it is segmented into translational research, and drug discovery & development. The drug discovery & development acquired the largest share in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to increase in application of spatial genomic and transcriptomics technologies in drug discovery & development. By end user, it is segmented into pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes.

The academic & research institutes segment acquired the largest share in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to surge in genomic research projects conducted by academic research institutes as well as collaboration among major players and universities for development of novel approaches to cure chronic conditions through genetic medicine.

Key Findings Of The Study


  • Based on technique, the spatial genomic analysis held largest share in the global market in 2020
  • Based on product type, the consumables held largest spatial genomics and transcriptomics market share in 2020 and is expected to remain dominant throughout the forecast period
  • By application, the drug discovery & development dominates the global spatial genomics and transcriptomic market in 2020 and is anticipated to continue this trend during the forecast period
  • By end user, the academic & research institutes held largest market share in 2020 and is anticipated to continue this trend during the forecast period
  • Based on region, North America is expected to experience growth at the highest rate, registering a CAGR of 106% during the forecast period
  • North America accounted for the largest share of the global spatial genomics and transcriptomic market in 2020, and is expected to remain dominant throughout the forecast period. This was attributed to presence of large number of key players as well as increase in number of large-scale genomics studies leveraging RNA sequencing in the region Furthermore, increasing adoption of personalized medicine for screening and diagnostics of genetic disorders is expected to further boost the market growth

Companies Mentioned

  • 10X Genomics, Inc.
  • Akoya Biosciences, Inc.
  • BioSpyder Technologies Inc.
  • Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.)
  • Dovetail Genomics, LLC
  • Fluidigm Corporation
  • Genomic Vision SA
  • Illumina, Inc.
  • Lunaphore Technologies SA
  • Nanostring Technologies, Inc.
  • Natera Inc.
  • PerkinElmer Inc. (Horizon Discovery Group Plc.)
  • Rarecyte, Inc.
  • Rebus Biosystems, LLC
  • Resolve Biosciences
  • S2 Genomic
  • Seven Bridges Genomics
  • Singular Genomics System, Inc.
  • Tecan Group Ltd. (Nugen Technologies, Inc.)
  • Ultivue, Inc.
  • Veranome Biosystems LLC
  • Vizgen Corporation.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information